Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Autoimmune Diseases, CNS

Explore clinical trials studying Demyelinating Autoimmune Diseases, CNS. Study availability and eligibility vary by location and protocol.

2,791 public trials 400 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Autoimmune Diseases, CNS trial results

Recruiting

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

NCT07477639

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Washington University, St. Louis St Louis, Missouri, United States
  • UC San Diego La Jolla, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Recruiting

A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)

NCT07503873

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • TG Therapeutics Investigational Trial Site Bihać, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Sarajevo, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Tuzla, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Zenica, Bosnia and Herzegovina
View all 39 locations
View Trial Details

Related conditions